MDxHealth Reports First Half Year 2014 Results
4 minutes ago - GlobeNewsWire via Dow Jones News
MDxHealth Reports First Half Year 2014 Results Strong market adoption leads to more than doubling of ConfirmMDx case volume IRVINE, Calif. and HERSTAL, Belgium, Aug. 21, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced results of the first-half year ended June 30, 2014.